Zimmer Holdings, Inc.

  • Why Are These 3 Spinal Treatment Companies Making Headlines?

    By Leo Sun - August 12, 2013 | Tickers: NUVA, OFIX, SYK, ZMH

    It’s been a busy, chaotic two weeks in the spinal and orthopedic devices market. Three major companies -- Stryker (NYSE: SYK), NuVasive (NASDAQ: NUVA), and Orthofix (NASDAQ: OFIX) -- recently made headlines for a myriad of reasons including FDA approvals, accusations of falsified Medicare and Medicaid claims, and an embarrassing restatement of past revenue. Let’s take a look at how these headlines are currently affecting these three stocks that have more »

  • Why Aren't Investors Worried About This Medical Devices Maker?

    By Leo Sun - July 23, 2013 | Tickers: GE, ICUI, SYK, ZMH

    When a company misses top and bottom line expectations and lowers its outlook, its stock usually plunges. However, medical device manufacturer Stryker Corp. (NYSE: SYK) appears to be immune to such concerns, and its stock has been flirting with 5-year highs daily despite reporting disappointing second quarter earnings that were plagued by a big product recall. Why are investors so optimistic regarding Stryker’s future growth prospects? Let’s take more »

  • The Market For This Company is Set to Explode

    By Mohammed Shaaban - July 16, 2013 | Tickers: JNJ, MAKO, SYK, ZMH

    After World War Two, The United States of America witnessed the largest population increase in its history. Birth rates reached 25 per 1000 people, while death rates hovered at 9.5 per 1000, resulting in what came to be known as the baby boomer generation. Born between 1946 and 1964, the age range of this generation is currently between 49 years and 67. 

    76 million strong, second only to millennials more »

  • Does the Decline in Health Care Spending Spell Trouble for These Companies?

    By Madhukar Dubey - July 9, 2013 | Tickers: BSX, STJ, ZMH

    Over the last few years the global healthcare industry has witnessed significant growth with most countries spending enormously on healthcare. The expenditure on health care varies widely; the U.S. spends the most, at approximately $8,500 per person in 2012.

    However, the outlook beyond 2013 looks hazy. Industry experts believe there could be a possible expenditure reduction of as much as $400 billion in the next three years by more »

  • These Companies Are Achieving Impressive Returns on Equity and Reducing Debt

    By Rupert Hargreaves - July 1, 2013 | Tickers: MRK, TIF, ZMH

    When it comes to investing, obviously making money is key and the best way to make money is to find the most profitable company set to generate huge amounts of cash in the future. More cash usually leads to a higher stock price and a fatter bank balance means there is potential for dividend checks, windfall payouts, or other shareholder returns.

    It is difficult trying to find these elusive companies more »

  • MAKO Surgical Battles Back into the Ring

    By Erik Eason - March 29, 2013 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

    MAKO Surgical’s (NASDAQ: MAKO) fourth-quarter results answered the mail on all three of the Market’s concerns: Strong sales of RIO surgical robots; Record number of surgical procedures; Pricing holds firm while the expense ratio continues to decline. It is a prize fighter back in the ring, yet the Market yawned. So what is it this time?

    In a nutshell: “Show me.” The market wants to see a sustained more »

  • This Niche Player Will Make Investors Rich

    By Ted Cooper - March 22, 2013 | Tickers: JNJ, SYK, ZMH

    A lot of investors feel safe buying enormous conglomerates that dominate an industry, but few take notice of smaller players that dominate a niche. That's part of the reason why Stryker Corp (NYSE: SYK) is on sale today at a price that could make investors rich.

    Thriving in its Niche

    Stryker is very good at inventing and producing orthopedic equipment. It basically expands the niche on its own by more »

  • 3 Stocks That Scream Buy Despite What Analysts Say

    By Michael Carter - January 28, 2013 | Tickers: AAPL, CMG, ZMH

    In 1995, one of my favorite stories of all time aired on ABC: The Langoliers.  The basic plot of the movie, based on the novel by Stephen King, is that an airplane full of passengers flies through a rip in the space-time continuum and results in the surviving crew traveling about 15 minutes into the past.  The news anchors I see on TV, author’s opinions I read about online more »

  • Will MAKO Get Back on its Feet?

    By Erik Eason - January 28, 2013 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

    MAKO Surgical (NASDAQ: MAKO) recently pre-released sales quantities to assuage the Market's anxiety, after a rough year of poor sales, over whether it would make its 2012 targets. The sales of RIO surgical robots (15 RIOs) was spot on the middle of their forecast range, and the number of procedures surged back up to an all-time high (2,904), which returned them close to their average number of procedures more »

  • Intuitive Surgical Q4 Earnings Preview: All Eyes On Japan

    By Daniel Sparks - January 9, 2013 | Tickers: ISRG, MAKO, MDT, SYK, ZMH

    In all of the last five quarters Intuitive Surgical (NASDAQ: ISRG) has topped estimates, with a surprise factor of about 5%. In four out of five of these quarters, Intuitive Surgical's stock price rose in the two days following the earnings announcement. So you can bet the pressure is on for Intuitive Surgical when it announces its fourth quarter earnings after the market closes on January 22. This quarter more »

  • 3 Long Ideas from Aberdeen Asset Management’s Top Buys

    By Shweta Dubey - November 9, 2012 | Tickers: XRX, XLNX, ZMH

    Aberdeen Asset Management is an investment and hedge fund management firm. The firm employs a bottom up approach to invest in global equities, with special emphasis on quality management teams and solid business models. I scanned Aberdeen’s top buys from the last quarter for ideas, and the following three stocks looks promising.


    P/E ratio (last 12 months)

    Industry P/E (last 12 months)

    Zimmer Holdings, Inc. (NYSE: ZMHmore »)

  • Was MAKO's Third Quarter Good Enough?

    By Steve Symington - November 9, 2012 | Tickers: HNSN, MAKO, SYK, ZMH

    Four weeks ago, I wondered in print whether MAKO Surgical's (NASDAQ: MAKO) third quarter results represented a breaking point for the company.  With MAKO's after-the-bell announcement yesterday, it's time to touch base to see how it fared.

    Third quarter revenue rose 46% from the same year-ago period to $29.2 million, with a net loss of $6.6 million, or 15 cents per share.  Perhaps most importantly more »

  • Earnings Report : MAKO Makes the Grade

    By Erik Eason - November 8, 2012 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

    MAKO Surgical's (NASDAQ: MAKO) 3rd quarter earnings report came out on Wednesday and it is, along with the subsequent conference call, chock full of valuable and detailed information. That's something I prize in CEO Maurice Ferré: He and his management team know what's important to MAKO's future, and they share a rich bounty of information on those topics.

    As a prelude to this earnings announcement, I more »

  • It's Showtime for MAKO

    By Erik Eason - October 25, 2012 | Tickers: ISRG, MAKO, SNN, SYK, ZMH | Editor's Choice

    MAKO Surgical's (NASDAQ: MAKO) earnings report is approaching, and much is riding on the results. Many eyes will read the report, and many ears will listen to the conference call. Let's be prepared so that we, as individual retail investors, can determine for ourselves whether MAKO is successfully navigating the difficult task of bringing mainstream customers onto their sales roster.

    As each earnings season approaches I like to more »

  • "The Undisputed Champion" in Robotics Based Surgery

    By Sandeep Gupta - September 19, 2012 | Tickers: COV, ISRG, MAKO, SYK, ZMH

    Medical robots should fall in the high tech consumers category as I don’t think it’s just the mechanical part that gives it its name, but a substantial amount of digital technology used to capture and process data to help manipulate the mechanical robot justifies its name. Definitely not all robots will be economic successes but it is a field worth exploring for investors. So far, Intuitive Surgical (NASDAQ: ISRGmore »)

  • Do Not Trust Humans, Trust Machines

    By Ankit Agrawal - September 17, 2012 | Tickers: ISRG, MAKO, ZMH

    MAKO Surgical (NASDAQ: MAKO) is a medical device company that provides a robotic technology platform (RIO) and orthopedic implants that enable minimally invasive MAKOplasty procedures for partial knee replacements and total hip replacements. This stock has seen a huge downfall of ~54% in the span of 4 months. Two events attributed to this giant fall (Click here to know about these events). The following graph shows the stock price movement more »

  • Will Organization Restructuring Increase Profits?

    By Ankit Agrawal - September 14, 2012 | Tickers: COV, STJ, SYK, ZMH

    St. Jude Medical (NYSE: STJ) is the leading developer and supplier of mechanical valves, and a top supplier in cardiac rhythm management (CRM) products and neuro-stimulation. In my view, St. Jude’s has strong long-term growth prospects given a replacement cycle tailwind and an upgraded product portfolio in CRM as well as leading positions in some of Med Tech's highest growth potential markets. Over the next few years, I more »

  • Who Will Win This Triple Threat Match?

    By Ankit Agrawal - September 7, 2012 | Tickers: MDT, SYK, ZMH

    Before writing this article, I went through portfolio of many hedge fund managers to find a suitable stock for analyzing. I found out that many of these portfolios have at least one stock from medical technology industry. So, I did a thorough research to find out the reasons for which top Hedge Fund and Mutual Fund experts like the Medical Equipment Industry and I found out that growth in emerging more »

  • Zimmer Holding Needs Implants to Perform

    By Ashish Sharma - August 24, 2012 | Tickers: JNJ, SYK, ZMH

    Zimmer Holdings (NYSE: ZMH) is the leading manufacturer of major joint (hip and knee) replacement and extremity (e.g., shoulder and elbow) implants.  Zimmer’s growth has been negatively impacted over the past several years by a combination of product recalls; the fallout from the DOJ investigation into the orthopedic industry; poor execution; and the weakened global economy. Late last month, Zimmer reported 2Q12 revenue of $1,125 million (down more »

  • Why I am Bullish on Johnson & Johnson

    By Ashish Sharma - August 24, 2012 | Tickers: JNJ, SYK, ZMH

    Johnson & Johnson (NYSE: JNJ) is one of the largest and most diversified healthcare businesses in the world, with over 200 operating companies encompassing a broad range of products across the healthcare field. The company's worldwide business is divided into three segments: Pharmaceutical (36% of sales), Medical Devices & Diagnostics (38%), and Consumer (26%). Even during unfavorable times for healthcare industry when some of its peers are struggling, Johnson & Johnson reported more »

  • Page 1 of 2